{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:00:02Z","timestamp":1788447602322,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.micpath.2024.106897","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:13:41Z","timestamp":1724796821000},"page":"106897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of the efficacy of Chitosan nanoparticles based on Rosuvastatin in the treatment of acute toxoplasmosis: An In vitro and In vivo study"],"prefix":"10.1016","volume":"195","author":[{"given":"Maryam","family":"Norouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Niyyati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghorbani-Bidkorpeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Javadi Mamaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Javad","family":"Seyyed Tabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2024.106897_bib1","first-page":"231","article-title":"Diagnosis of toxoplasma infection in allogenic pre HCTSP patients using molecular methods","volume":"17","author":"Yusefi","year":"2022","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.micpath.2024.106897_bib2","article-title":"Candidate antigenic epitopes for vaccination and diagnosis strategies of Toxoplasma gondii infection: a review","volume":"137","author":"Mamaghani","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2024.106897_bib3","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s10989-020-10021-x","article-title":"Designing diagnostic kit for Toxoplasma gondii based on GRA7, SAG1, and ROP1 Antigens: an in silico strategy","volume":"26","author":"Javadi Mamaghani","year":"2020","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.micpath.2024.106897_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2024.106897_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12639-017-0973-8","article-title":"Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice","volume":"42","author":"Etewa","year":"2018","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.micpath.2024.106897_bib6","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1242\/jcs.108.6.2457","article-title":"Invasion of Toxoplasma gondii occurs by active penetration of the host cell","volume":"108","author":"Morisaki","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.micpath.2024.106897_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003665","article-title":"Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.106897_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-2-3","article-title":"Applications of nanoparticles in biology and medicine","volume":"2","author":"Salata","year":"2004","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.micpath.2024.106897_bib9","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.2174\/138161281941131219135458","article-title":"Nanotechnological strategies for the treatment of neglected diseases","volume":"19","author":"Khalil","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.micpath.2024.106897_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","article-title":"Polysaccharide colloidal particles as delivery systems for macromolecules","volume":"47","author":"Janes","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2024.106897_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/1061186X.2011.654121","article-title":"Chitosan nanoparticles: a survey of preparation methods","volume":"20","author":"Grenha","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.micpath.2024.106897_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/IJN.S158736","article-title":"Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain","author":"Teimouri","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2024.106897_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2019.107717","article-title":"Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles","volume":"204","author":"Hagras","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2024.106897_bib14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1023\/A:1012128907225","article-title":"Chitosan and chitosan\/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines","volume":"14","author":"Calvo","year":"1997","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.micpath.2024.106897_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0031182019001604","article-title":"Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis in vivo model and influenced the neuropathological pattern of ME-49 strain","volume":"147","author":"Nishi","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2024.106897_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250079","article-title":"Rosuvastatin revert memory impairment and anxiogenic-like effect in mice infected with the chronic ME-49 strain of Toxoplasma gondii","volume":"16","author":"Evangelista","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.106897_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/23.suppl_A.77","article-title":"Toxoplasmosis in AIDS patients","volume":"23","author":"Tuazon","year":"1989","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.106897_bib18","first-page":"82","article-title":"Seroprevalence of Toxoplasma gondii in pregnant women and bioassay of IgM positive cases in Zanjan, Northwest of Iran","volume":"7","author":"Hajsoleimani","year":"2012","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.micpath.2024.106897_bib19","first-page":"474","article-title":"Frequency of Toxoplasma gondii in HIV positive patients from West of Iran by ELISA and PCR","volume":"9","author":"Rostami","year":"2014","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.micpath.2024.106897_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11845-022-02998-9","article-title":"Toxoplasma gondii vaccine candidates: a concise review","volume":"192","author":"Mamaghani","year":"2023","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.micpath.2024.106897_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkl180","article-title":"Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro","volume":"58","author":"Martins-Duarte","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.106897_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2017.09.051","article-title":"Atovaquone oral bioavailability enhancement using electrospraying technology","volume":"111","author":"Darade","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2024.106897_bib23","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ijbiomac.2017.10.086","article-title":"Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: development and in vitro and in vivo evaluations","volume":"107","author":"Hirpara","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2024.106897_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1567201818666210609165630","article-title":"Fabrication of chitosan-coated mesoporous silica nanoparticles bearing rosuvastatin as a drug delivery system","volume":"19","author":"Ghahfarokhi","year":"2022","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.micpath.2024.106897_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.9734\/jpri\/2020\/v32i130394","article-title":"Chitosan-sodium alginate nanoparticle as a promising approach for oral delivery of rosuvastatin calcium: formulation, optimization and in vitro characterization","volume":"32","author":"Mujtaba","year":"2020","journal-title":"Journal of pharmaceutical research international"},{"key":"10.1016\/j.micpath.2024.106897_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exppara.2017.07.009","article-title":"Activity of rosuvastatin in tachyzoites of Toxoplasma gondii (RH strain) in HeLa cells","volume":"181","author":"Sanfelice","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2024.106897_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02628-16","article-title":"Synergistic activity between statins and bisphosphonates against acute experimental toxoplasmosis","volume":"61","author":"Li","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.106897_bib28","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1292\/jvms.18-0344","article-title":"How does Toxoplama gondii invade host cells?","volume":"80","author":"Kato","year":"2018","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.micpath.2024.106897_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fcimb.2019.00103","article-title":"Mechanisms of human innate immune evasion by Toxoplasma gondii","volume":"9","author":"Lima","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2024.106897_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010268","article-title":"The powerful synergistic effect of spiramycin\/propolis loaded chitosan\/alginate nanoparticles on acute murine toxoplasmosis","volume":"16","author":"Hagras","year":"2022","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024003644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024003644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T07:09:44Z","timestamp":1726297784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401024003644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"alternative-id":["S0882401024003644"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106897","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the efficacy of Chitosan nanoparticles based on Rosuvastatin in the treatment of acute toxoplasmosis: An In vitro and In vivo study","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106897"}}